Keymed Biosciences, Inc. had a revenue of 498.75M in the quarter ending Jun 30, 2025, with 33.56%. This bring the company's revenue in the last twelve months to 872.19M, Decreased 103.72%. In the fiscal year ending Dec 31, 2024, Keymed Biosciences, Inc. had annual revenue of 428.12M with 20.91% growth.